These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 10090435)

  • 21. A clinical trial of trimethobenzamide/diphenhydramine versus sumatriptan for acute migraines.
    Friedman BW; Hochberg M; Esses D; Bijur PE; Corbo J; Paternoster J; Solorzano C; Toosi B; Lipton RB; Gallagher EJ
    Headache; 2006 Jun; 46(6):934-41. PubMed ID: 16732839
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized, double-blind, placebo-controlled trial of the efficacy and tolerability of a 4-mg dose of subcutaneous sumatriptan for the treatment of acute migraine attacks in adults.
    Wendt J; Cady R; Singer R; Peters K; Webster C; Kori S; Byrd S
    Clin Ther; 2006 Apr; 28(4):517-26. PubMed ID: 16750463
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of almotriptan 12.5 mg in achieving migraine-related composite endpoints: a double-blind, randomized, placebo-controlled study in patients controlled study in patients with previous poor response to sumatriptan 50 mg.
    Diener HC
    Curr Med Res Opin; 2005 Oct; 21(10):1603-10. PubMed ID: 16238900
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Almotriptan in migraine patients who respond poorly to oral sumatriptan: a double-blind, randomized trial.
    Diener HC; Gendolla A; Gebert I; Beneke M
    Headache; 2005; 45(7):874-82. PubMed ID: 15985104
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of clinical, service, and cost outcomes of a conversion program of sumatriptan to rizatriptan ODT in primary care patients with migraine headaches.
    Gershovich OE; Billups SJ; Delate T; Hoffman CK; Carroll N
    J Manag Care Pharm; 2006 Apr; 12(3):246-53. PubMed ID: 16623609
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-effectiveness and cost-benefit of sumatriptan in patients with migraine.
    Lofland JH; Kim SS; Batenhorst AS; Johnson NE; Chatterton ML; Cady RK; Kaniecki R; Nash DB
    Mayo Clin Proc; 2001 Nov; 76(11):1093-101. PubMed ID: 11702897
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and tolerability of sumatriptan injection for the treatment of morning migraine: two multicenter, prospective, randomized, double-blind, controlled studies in adults.
    Winner P; Adelman J; Aurora S; Lener ME; Ames M
    Clin Ther; 2006 Oct; 28(10):1582-91. PubMed ID: 17157114
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of migraine and migraine therapy on productivity and quality of life.
    Solomon GD; Santanello N
    Neurology; 2000; 55(9 Suppl 2):S29-35. PubMed ID: 11089517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of migraine and response to sumatriptan in patients self-reporting tension/stress headache.
    Kaniecki R; Ruoff G; Smith T; Barrett PS; Ames MH; Byrd S; Kori S
    Curr Med Res Opin; 2006 Aug; 22(8):1535-44. PubMed ID: 16870078
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of sumatriptan on workplace productivity, nonwork activities, and health-related quality of life among hospital employees with migraine.
    Mushet GR; Miller D; Clements B; Pait G; Gutterman DL
    Headache; 1996 Mar; 36(3):137-43. PubMed ID: 8984084
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sumatriptan-naproxen sodium for menstrual migraine and dysmenorrhea: satisfaction, productivity, and functional disability outcomes.
    Cady RK; Diamond ML; Diamond MP; Ballard JE; Lener ME; Dorner DP; Derosier FJ; McDonald SA; White J; Runken MC
    Headache; 2011 May; 51(5):664-73. PubMed ID: 21521204
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Satisfaction with current migraine therapy: experience from 3 centers in US and Sweden.
    Bigal M; Rapoport A; Aurora S; Sheftell F; Tepper S; Dahlof C
    Headache; 2007 Apr; 47(4):475-9. PubMed ID: 17445096
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of sumatriptan 50 mg in patients not responding to standard care, in the treatment of mild to moderate migraine. The Sumatriptan 50 mg Italian Study Group.
    Pini LA; Fabbri L; Cavazzuti L
    Int J Clin Pharmacol Res; 1999; 19(2):57-64. PubMed ID: 10669900
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of sumatriptan tablets in migraineurs self-described or physician-diagnosed as having sinus headache: a randomized, double-blind, placebo-controlled study.
    Ishkanian G; Blumenthal H; Webster CJ; Richardson MS; Ames M
    Clin Ther; 2007 Jan; 29(1):99-109. PubMed ID: 17379050
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral sumatriptan for the acute treatment of probable migraine: first randomized, controlled study.
    Tepper SJ; Cady R; Dodick D; Freitag FG; Hutchinson SL; Twomey C; Kuhn TA
    Headache; 2006 Jan; 46(1):115-24. PubMed ID: 16412159
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Economic burden of transformed migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study.
    Munakata J; Hazard E; Serrano D; Klingman D; Rupnow MF; Tierce J; Reed M; Lipton RB
    Headache; 2009 Apr; 49(4):498-508. PubMed ID: 19245386
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patient-selected dosing in a six-month open-label study evaluating oral sumatriptan in the acute treatment of migraine. Sumatriptan Tablets S2CM10 Study Group.
    Dowson AJ; Ashford EA; Prendergast S; Hassani H; Roberts GW; Flöter T; Szczudlik A
    Int J Clin Pract Suppl; 1999 Aug; 105():25-33. PubMed ID: 10692719
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness of a group outpatient visit model for chronically ill older health maintenance organization members: a 2-year randomized trial of the cooperative health care clinic.
    Scott JC; Conner DA; Venohr I; Gade G; McKenzie M; Kramer AM; Bryant L; Beck A
    J Am Geriatr Soc; 2004 Sep; 52(9):1463-70. PubMed ID: 15341547
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fixed-dose sumatriptan and naproxen in poor responders to triptans with a short half-life.
    Mathew NT; Landy S; Stark S; Tietjen GE; Derosier FJ; White J; Lener SE; Bukenya D
    Headache; 2009 Jul; 49(7):971-82. PubMed ID: 19486178
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of a fast disintegrating/rapid release oral formulation of sumatriptan on functional ability in patients with migraine.
    Barbanti P; Carpay JA; Kwong WJ; Ahmad F; Boswell D
    Curr Med Res Opin; 2004 Dec; 20(12):2021-9. PubMed ID: 15701219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.